Optimal Active Anti-Thymocyte Globulin Exposure Associated with Minimum Risk of Virus Reactivation and Comparable Acute Graft-Versus-Host Disease Under Adult Myeloablative Haploidentical Peripheral Blood Stem Cell TransplantationHaitao Wang, Dai‐Hong Liu, Jishan Du et al.|Transplantation and Cellular Therapy|2022Cited by 16
Transcriptome-Wide Analysis of RNA N6-Methyladenosine Modification in Adriamycin-Resistant Acute Myeloid Leukemia CellsShu Fang, Liping Dou, Bo Peng et al.|Frontiers in Genetics|2022Cited by 15
Outcome of Rituximab-Based Treatment for Post-Transplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center ExperienceChengying Zhu, Chunji Gao, Shasha Zhao et al.|Annals of Transplantation|2019Cited by 14
Outcome and Prognostic Factors of High-Risk Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell TransplantationChengying Zhu, Chunji Gao, Guofeng Chen et al.|Annals of Transplantation|2019Cited by 14
High Risk of Recurrence of Malignancy Noted in Four-day rATG Regimen After Allogeneic PBSCT From Matched Sibling DonorsNan Wang, Dai‐Hong Liu, Haitao Wang et al.|Transplantation and Cellular Therapy|2022Cited by 4